Author |
Type of Study |
Participants |
Findings |
Lips et al. [14] |
Review |
|
Low vitamin D is associated with insulin resistance and type 2 diabetes. |
Marino and Misra [15] |
Review |
|
Low vitamin D has a role in the development of Type1 DM, suggested by the presence of vitamin D response element in the human insulin gene promoter. In addition, vitamin D regulates T-cell responses and may protect beta cells from immune attacks. |
Infante et al. [16] |
Review |
|
Hypovitaminosis D is an important environmental factor in the development of T1D and may have a role in the pathogenesis and determining the risk of development in the first years of life. However, evidence on vitamin D supplementation and beta-cell function preservation in T1D is still lacking. |
Wang et al. [18] |
case-control study |
2659 Chinese participants |
They found that low serum levels of 25(OH)D3,25(OH)D2 were associated with impaired fasting glucose in patients with T2DM; they explained this negative relationship to be due to altering lipid metabolism and altering the concentration of total cholesterol, low-density lipoprotein cholesterol high-density lipoprotein which leads to impaired fasting glucose and type 2 DM. |
Aljabri and Bokhari [19] |
clinical trial |
Eighty participants with T1D whose vitamin D levels were below 50 nmol/L |
Low vitamin D is associated with insulin resistance and beta cell death, contributing to the development of T1D. Additionally, Vitamin D supplementation improved glycemic control in T1D patients. |
Najjar et al. [20] |
systematic review and meta-analysis, including10 studies |
|
No major effect of genetically determined reduction of 25(OH)D concentrations by selected polymorphisms on T1D risk. |
Zheng et al. [21] |
meta-analysis |
120618 participants of European descent |
MR analysis revealed a lack of evidence for a causal link between 25(OH)D and T2D despite a high inverse observational association between the two diseases. The result was against the use of Vit D supplements to prevent T2D. |
Li et al. [22] |
systematic review and meta-analysis, including 20 RCTs |
2703 participants. |
Vitamin D supplementation successfully enhanced serum 25(OH)D and improved insulin resistance. |
Jennifer et al. [23] |
A systematic review, including 35 (RCTs) |
43407 diabetic patients |
They found that supplementation with vitamin D does not appear to enhance glycemic control or insulin resistance in the short term. |
Pittas et al. [24] |
Randomized control trial |
2423 |
In people at high risk of type 2 diabetes who were not specifically chosen for vitamin D deficiency, vitamin D3 treatment at a level of 4000 IU per day did not result in a significantly reduced risk of diabetes than placebo. |
Zhao et al. [25] |
A meta-analysis, including four prospective cohort studies |
187592 participants and 9456 incident cases |
They found no connection between total vitamin D intake and the incidence of type 2 diabetes. |
Mohammadian et al. [26] |
Systematic review and meta-analysis |
44 patients with T1D who were younger than 17 years old |
HbA1C improves with vitamin D3 supplementation in all glycemic control groups in children with T1D and vitamin D insufficiency. |